Receptor Tyrosine Kinase Inhibitor Nintedanib as Treatment Option in Bronchiolitis Obliterans after Airway Transplantation

Heim C, Mauer J, Kuckhahn A, Distler J, Spriewald B, Ramsperger-Gleixner M, Weyand M, Ensminger SM (2019)

Publication Type: Conference contribution

Publication year: 2019

Journal

Journal of Heart and Lung Transplantation Elsevier

Publisher: ELSEVIER SCIENCE INC

City/Town: NEW YORK

Pages Range: S139-S139

Conference Proceedings Title: JOURNAL OF HEART AND LUNG TRANSPLANTATION

Event location: Orlando, FL US

DOI: 10.1016/j.healun.2019.01.331

Authors with CRIS profile

Christian Heim Department of Cardiac Surgery Jörg Distler Professur für Molekulare Mechanismen der Organfibrose Martina Ramsperger-Gleixner Department of Cardiac Surgery Michael Weyand Lehrstuhl für Herzchirurgie

Involved external institutions

Universität zu Lübeck DE Germany (DE)

How to cite

APA:

Heim, C., Mauer, J., Kuckhahn, A., Distler, J., Spriewald, B., Ramsperger-Gleixner, M.,... Ensminger, S.M. (2019). Receptor Tyrosine Kinase Inhibitor Nintedanib as Treatment Option in Bronchiolitis Obliterans after Airway Transplantation. In JOURNAL OF HEART AND LUNG TRANSPLANTATION (pp. S139-S139). Orlando, FL, US: NEW YORK: ELSEVIER SCIENCE INC.

MLA:

Heim, Christian, et al. "Receptor Tyrosine Kinase Inhibitor Nintedanib as Treatment Option in Bronchiolitis Obliterans after Airway Transplantation." Proceedings of the 39th Annual Meeting and Scientific Sessions of the International-Society-for-Heart-and-Lung-Transplantation (ISHLT), Orlando, FL NEW YORK: ELSEVIER SCIENCE INC, 2019. S139-S139.

BibTeX: Download